Coty announced that Swarovski has signed a long-term beauty license that offers the opportunity to develop, produce and distribute a collection of fragrances.
Looking to offset declining margins, generic drug suppliers are diversifying capabilities and emphasizing specialty products, biosimilars and patient services.
